SUGAR LAND--March 20, 2018--Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas)-- The Pharmaceutical-Biotech Industry is on track to complete construction on 383 North American capital and maintenance projects in the first quarter of 2018. A recent survey of reported projects in Industrial Info's Pharmaceutical-Biotech Online Platform reveals that the projects have a total investment value (TIV) of $4.6 billion.
Within this article: Details of major U.S. Pharma-Biotech project completions
Companies featured: Jacobs Engineering Group Incorporated (NYSE:JEC), Bristol-Myers Squibb Company (NYSE:BMY)
(All Fields Required)